台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效

佳醫

(4104)
可現股當沖
  • 股價
    91.4
  • 漲跌
    ▼0.2
  • 漲幅
    -0.22%
  • 成交量
    124
  • 產業
    上市 生技醫療類股
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
佳醫 (4104)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/15     後一日»

券商獲利排行 - 2024/04/15

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  5.38%269.30269.3-5205296.2096.291
  4.33%254.6-5.4260-48126196.496.896.391
  4.94%209.8-1.2211-3954496.496.696.491
  5.38%191.90.2191.7-3613796.396.196.391
  5.16%164.3-0.9165.2-3033396.596.896.591
  5.84%124.20124.2-2102296.696.396.691
  4.31%107.7-3.1110.8-2242696.196.89691
  5.74%88.7088.7-1601696.5096.591
  3.86%52.11.650.5-851496.596.396.691
  5.30%50.9050.9-1001096.1096.191
  5.01%43.2043.2-90995.8095.891
  5.58%43043-80896.4096.491
  3.53%27.20.626.6-43896.396.196.391
  5.97%23.1023.1-30496.896.496.891
  4.36%210.220.8-31596.29696.291
  6.19%18018-3039709791
  6.19%18018-3039709791
  6.15%17.9017.9-3039709791
  5.70%16.5016.5-30396.5096.591
  4.13%15.9015.9-31496.396.396.391
  5.22%15015-3039609691
  6.09%11.8011.8-20296.9096.991
  5.90%11.4011.4-10296.796.296.791
  5.89%11.4011.4-10296.796.496.791
  5.70%11011-20296.596.996.591
  5.65%10.9010.9-20296.5096.591
  5.41%10.4010.4-20296.2096.291
  5.31%10.2010.2-20296.1096.191
  3.51%10.1010.1-21396969691
  5.21%10010-2029609691
  2.28%6.60.85.8-12396.796.596.891
  2.08%60.65.4-12396.396.196.491
  6.19%6060019796.79791
  6.09%5.905.9-10196.9096.991
  6.09%5.905.900196.996.596.991
  6.08%5.905.9-10196.9096.991
  5.99%5.805.8-10196.8096.891
  5.99%5.805.8-10196.8096.891
  5.89%5.705.7-10196.7096.791
  5.80%5.605.6-10196.6096.691
  5.80%5.605.6-10196.6096.691
  5.62%5.405.4-10196.4096.491
  5.50%5.305.300196.396.696.391
  5.44%5.205.2-10196.2096.291
  5.42%5.205.2-10196.2096.291
  5.41%5.205.2-10196.2096.291
  5.41%5.205.2-10196.2096.291
  5.41%5.205.200196.296.496.291
  5.22%505-1019609691
  5.21%505-1019609691

券商虧損排行 - 2024/04/15

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -5.87%-62.40-62.41111096.796.7091
  -5.29%-610-611212096.196.1091
  -5.47%-52.70-52.71010096.396.3091
  -5.40%-52.3-0.1-52.2810196.896.896.791
  -5.21%-500-50101009696091
  -5.21%-500-50101009696091
  -6.11%-47.40-47.488096.996.9091
  -5.12%-39.30-39.388095.995.9091
  -5.02%-38.7-0.2-38.568196.596.596.391
  -5.71%-38.60-38.677096.596.5091
  -5.32%-30.70-30.766096.196.1091
  -5.21%-300-306609696091
  -5.99%-290-2945096.896.896.491
  -4.27%-28.9-0.1-28.857296.796.896.791
  -5.80%-280-2855096.696.6091
  -5.41%-260-2655096.296.2091
  -5.40%-260-2655096.296.296.591
  -5.32%-25.50-25.555096.196.1091
  -5.21%-250-255509696091
  -5.99%-23.20-23.234096.896.896.591
  -5.72%-22.10-22.134096.596.59791
  -5.70%-220-2244096.596.5091
  -4.54%-21.9-0.4-21.545196.396.49691
  -5.46%-210-2144096.396.3091
  -5.45%-210-2144096.396.3091
  -5.43%-20.90-20.944096.296.2091
  -4.19%-20.20.7-20.945196.396.296.991
  -5.21%-200-204409696091
  -5.11%-19.60-19.644095.995.9091
  -5.86%-170-1723096.796.796.691
  -5.81%-16.80-16.833096.696.6091
  -3.42%-16.5-0.4-16.135296.396.496.291
  -5.60%-16.20-16.233096.496.496.791
  -5.44%-15.70-15.733096.296.2091
  -5.34%-15.40-15.433096.196.1091
  -5.31%-15.30-15.333096.196.1091
  -5.31%-15.30-15.333096.196.1091
  -5.27%-15.20-15.223096.196.196.291
  -5.27%-15.20-15.233096.196.1091
  -5.24%-15.10-15.13309696091
  -5.21%-150-153309696091
  -5.21%-150-153309696091
  -0.71%-13.8-13.800202096.696.996.291
  -6.38%-12.40-12.422097.297.2091
  -6.19%-120-1212096.99796.591
  -6.19%-120-122209797091
  -6.09%-11.80-11.822096.996.9091
  -5.98%-11.60-11.622096.896.8091
  -5.85%-11.30-11.322096.796.7091
  -5.84%-11.30-11.322096.696.6091
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音